profit from every $100 of sales.
$0$100
Legato Merger Corp. IV
$10.01+0.00% today
+0.6% since Mar 16, 26
1-year low $9.801-year high $10.08
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Legato Merger Corp. IV vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Legato Merger Corp. IV | No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads Legato Merger Corp. IV's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- 0.0×
- –
- –
- –
- –
- –
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- –
- 0.0%
- 0.0%
- 0.0%
- –
Growth
- –
- –
- –
- –
- –
Financial health
- 0.0×
- 2.58
- 60.7%
- –
- 0.05
- 0.05
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 15%of 667
Bottom 9%of 522
News
Lego posts record first-half revenue, CEO touts strong sales at high-end and value pricingCNBC · Aug 25, 2026The newest story we have is from Aug 25, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
49No pass
Philip Fisher
43No pass
Peter Lynch
17No pass
Joel Greenblatt
0No pass
Charlie Munger
22No pass
Terry Smith
25No pass
Questions about Legato Merger Corp. IV
Is Legato Merger Corp. IV a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Legato Merger Corp. IV AI analysis
What does Legato Merger Corp. IV do?
Legato Merger Corp. IV focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. It is in Shell Companies.
Does Legato Merger Corp. IV pay a dividend?
No. Legato Merger Corp. IV does not pay a dividend at the moment.
Is Legato Merger Corp. IV stock halal?
Questionable. Legato Merger Corp. IV sits in a grey zone: scholars disagree about its industry. How we check
Who are Legato Merger Corp. IV's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with Legato Merger Corp. IV's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.